Benzinga | Nov 6, 2020 07:31AM EST

Cytokinetics Highlights 6 Presentations Related To Heart Failure, Hypertrophic Cardiomyopathy At American Heart Association Scientific Sessions Nov. 12 2:30-3:30 p.m. EST

Cytokinetics, Incorporated (NASDAQ:CYTK) today announced six presentations at the American Heart Association (AHA) Scientific Sessions 2020, taking place online from November 13, 2020 -- November 17, 2020, including the presentation of primary results from GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure), the Phase 3 event driven cardiovascular outcomes clinical trial of omecamtiv mecarbil, in a Late Breaking Clinical Trial session, as well as five poster presentations.

Results from GALACTIC-HF, one of the largest heart failure trials ever conducted, will be presented at a live, virtual, embargoed AHA News Briefing on Thursday, November 12, 2020 from 1:30-2:30 PM CT.

Late Breaking Clinical Trial Session

Title: Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: The Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure (GALACTIC-HF) Trial

Session: LBS.01 - Heart Failure and Atrial Fibrillation: Vitamins, Minerals, Nutrients, and More

Speaker: John Teerlink, M.D., Professor of Medicine, University of California San Francisco, Director of Heart Failure, San Francisco Veterans Affairs Medical Center and Executive Committee Chair, GALACTIC-HF

Date: November 13, 2020

Presentation Time: 10:35 -- 10:45 AM CT

Cytokinetics Investor/Media Event

Cytokinetics will host an investor/media event related to the results of GALACTIC-HF on November 13, 2020 at 1:00 PM ET that will be simultaneously webcast and can be accessed at https://wsw.com/webcast/cc/cytk/1388034 or by visiting the Investors & Media section of Cytokinetics' website at www.cytokinetics.com. An archived replay of the virtual event will be available via Cytokinetics' website until November 13, 2021. Members of Cytokinetics' senior management will be joined by the following physician experts:

* John Teerlink, M.D., Professor of Medicine, University of California San Francisco, Director of Heart Failure, San Francisco Veterans Affairs Medical Center and Executive Committee Chair, GALACTIC-HF

* G. Michael Felker, M.D., M.H.S, Professor of Medicine, Vice-Chief of Cardiology for Clinical Research, Duke University School of Medicine and Director of Cardiovascular Research, Duke Clinical Research Institute

* Scott Solomon, M.D., Edward D. Frohlich Distinguished Chair, Professor of Medicine, Harvard Medical School and Director of Noninvasive Cardiology, Brigham and Women's Hospital

* Nihar R. Desai, M.D., MPH, Associate Professor of Medicine, Associate Chief, Cardiovascular Medicine, Yale School of Medicine, Center for Outcomes Research and Evaluation

ePosters On Demand

The following posters will be available on demand from the start of the conference on November 13, 2020 at 9:00 AM CT until the end of the conference on November 17, 2020, 8:30 PM CT.

Title: The Cardiac Myosin Inhibitor, CK-3772271, Attenuates Cardiac Fibrosis and Diastolic Dysfunction in the Dahl/Salt Sensitive Rat Model of Heart Failure With Preserved Ejection Fraction

Session MP.APS.05 - Heart Failure I

Presenter Darren Hwee, Ph.D., Associate Director, Pharmacology, Cytokinetics

Poster Number P1762

Title: Pharmacodynamic Effects of a Single Dose of CK-3773274 in Cats With Hypertrophic Cardiomyopathy

Session: CE.APS.01 - Protein Dysfunction in Heart Failure

Presenter Joshua Stern, D.V.M., Ph.D., Associate Professor & Chief of Service: Cardiology, School of Veterinary Medicine, University of California, Davis

Poster Number P756

Title: Demographic and Clinical Characteristics of Patients With Obstructive Hypertrophic Cardiomyopathy in a Large, Nationwide Us Cohort

Session HF.APS.29 - Different Aspects of Hypertrophic Cardiomyopathy

Presenter: Michael Butzner, MPH, CCRP, HEOR Consultant, Cytokinetics

Poster Number P1735

Title: Thirty Day Episode of Care Spending Following Heart Failure Hospitalization Among Medicare Beneficiaries With Heart Failure

Session HF.APS.17 - Heart Failure Quality of Care and Process Improvement

Presenter: Nihar R. Desai, M.D., MPH, Yale University School of Medicine

Poster Number P975

Title: Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and a Worsening Heart Failure Event

Session HF.APS.11 - Acute and Advanced Heart Failure

Presenter: Anthony P. Carnicelli, M.D., Duke Clinical Research Institute -- DCRI

Poster Number P427